The FDA has granted Mercury Computer Systems approval for the company’s Visage® CS Thin Client version 3.1. The package allows for sharing and analyzing of 3-D tomographic images on standard laptop and desktop computers.
Here are some features from the product brochure:
Advances in CT and MR Angiography
Visage provides a rich and efficient set of tools for visualizing, analyzing, and post processing contrast-enhanced
and/or time-resolved CTA and MRA studies. Key new features in version 3.1 include:
• Multiple new 2D and 3D ROI types
• Time-value curves for arbitrary ROIs
• Semi-automatic editing tools for separating vessels, bone, and other structures
• Curved reformatting with the possibility of generating curved stacks and rotations
• Significantly enhanced 3D slab as well as editing and visualization of 3D segmentations
Cardiac Analysis Option – Stronger than Ever
Visage offers the only comprehensive 3D thin client solution for cardiac CT, including protocols and tools for calcium scoring, coronary artery analysis, and left ventricle analysis. New cardiac CT features in 3.1 include:
• Calcium scoring, coronary artery and left ventricle analyses
• Powerful 3D editing functions
• Automatic chest wall removal
• Myocardial mass calculation
New in 3.1: Neuro Option
This newly introduced product option provides efficient perfusion analysis tools for time-resolved CT and MR images of the brain. With Visage CS, perfusion analysis becomes available everywhere and anywhere you need it – in the emergency room, radiology reading room, home office, or wherever you have internet access.
Features include:
• Temporal MIP and MinIP (tMIP)
• Mean transit time (MTT)
• Time to peak (TTP)
• Cerebral blood volume
• Cerebral blood flow (CBF)
• ROI-based symmetry analysis
New in 3.1: Oncology Option
The new oncology product option provides multiple tools for the quantification and comparison of 2D and 3D
pathological structures. This includes a rich toolset for annotating, marking and measuring lesions in 2D and 3D as well as for comparing lesions in follow up exams. Additionally, SUV based ROI analysis for PET-CT can be performed easily and efficiently.
• PET/CT SUV calculation for 2D and 3D ROIs
• Different SUV types and manual editing of SUV parameters
• Semi-automatic 3D segmentation of small lesions in CT, MR, and PET-CT
• Efficient workflow for annotating and comparing lesions in multiple exams
Press release: Visage Imaging Receives FDA 510(k) Clearance for its Latest Thin Client Product Release …
Visage CS 3.1 product brochure…
